Andrew Calinisan
Andrew Calinisan publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Protein Kinase Regulation and GTPase Signaling, Cancer-related gene regulation and Epigenetics and DNA Methylation.
- World rank
- #532,224 of 7,710,434 ranked researchers
- Rank in United States
- #184,450 of 1,627,098
- Works
- 98
- Citations
- 3k
- Citations per work
- 30.1
What does Andrew Calinisan research?
Andrew Calinisan's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Medicine (33%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences5050.7%
- Health Sciences3233.0%
- Medicine3233.0%
- Everything else1413.8%
- Physical Sciences22.5%
- Chemistry22.5%
- 1Molecular Biology42% of their works
- 2Oncology24% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Cancer Research5% of their works
- 5Immunology4% of their works
- 6Organic Chemistry2% of their works
Research topics
Which keywords describe Andrew Calinisan's research?
The keywords of their largest research topics: Cancer Therapy, Transcriptional Regulation, Oncogenic Mutations, Cell Proliferation, Cancer, Protein Kinases, Ras Signaling and Arginine Methylation.
- Signaling
- Enzyme Regulation
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- DNA Methylation
- BRAF gene
- Arginine Methylation
- Protein Kinases
- Cell Proliferation
- Transcriptional Regulation
- Cancer Therapy
- Oncogenic Mutations
- Cancer
- Ras Signaling
- Protein Arginine Methyltransferases
- Cell Cycle
- Histone Modification
- MAP Kinase
- p53
- Nucleotide Metabolism
- mTOR
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cancer Therapy143 topics
- Transcriptional Regulation112 topics
- Oncogenic Mutations102 topics
- Cell Proliferation92 topics
- Cancer82 topics
- Protein Kinases61 topic
- Ras Signaling61 topic
- Arginine Methylation51 topic
- Protein Arginine Methyltransferases51 topic
- BRAF gene41 topic
- Cell Cycle41 topic
- DNA Methylation41 topic
- Histone Modification41 topic
- Immune Checkpoint Blockade41 topic
- MAP Kinase41 topic
- PD-1 and PD-L141 topic
- p5341 topic
- Enzyme Regulation31 topic
- Nucleotide Metabolism31 topic
- Signaling31 topic
- mTOR31 topic
Where does Andrew Calinisan work?
Andrew Calinisan's main affiliation in the publication record is Mirati Therapeutics (United States), United States.
How many publications and citations does Andrew Calinisan have?
OpenAlex counts 98 works and 2,950 citations for Andrew Calinisan, an h-index of 9, ranking #532,224 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew Calinisan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.